These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18815932)

  • 1. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New WHO classification of urothelial carcinoma of the urinary bladder].
    Helpap B
    Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic modeling of human urinary bladder carcinogenesis.
    Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
    Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
    Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
    Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
    Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
    Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
    Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
    J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent FGFR3 mutations in urothelial papilloma.
    van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
    J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the diagnosis of urothelial neoplasia.
    Crissman JD; Zarbo RJ; Johnson T; Babu VR; Sarkar FH; Miles BJ; Cerny JC
    Henry Ford Hosp Med J; 1989; 37(1):19-23. PubMed ID: 2670840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
    Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
    J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
    Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
    Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
    Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
    Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.